Differences in Pulmonary Artery Flow Hemodynamics Between PAH and PH‐HFpEF: Insights From 4D‐Flow CMR

ABSTRACT Pulmonary artery (PA) flow analysis is crucial for understanding the progression of pulmonary hypertension (PH). We hypothesized that PA flow characteristics vary according to PH etiology. In this study, we used 4D flow cardiovascular magnetic resonance imaging (CMR) to compare PA flow velo...

Full description

Bibliographic Details
Published in:	Pulmonary Circulation
Main Authors:	Bong‐Joon Kim, Jeesoo Lee, Haben Berhane, Benjamin H. Freed, Sanjiv J. Shah, James D. Thomas
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Subjects:	4D‐flow CMR heart failure with preserved ejection fraction with pulmonary hypertension pulmonary arterial hypertension pulmonary artery flow hemodynamics
Online Access:	https://doi.org/10.1002/pul2.70022

Similar Items

Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension
by: Xiaodan Zhao, et al.
Published: (2022-12-01)

Hemodynamics assessment using 4D flow CMR before and after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a retrospective observational study
by: Kazuto Ohno, et al.
Published: (2025-08-01)

Left atrial acceleration factor as a magnetic resonance 4D flow measure of mean pulmonary artery wedge pressure in pulmonary hypertension
by: Gert Reiter, et al.
Published: (2022-08-01)

Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP)
by: Carlos Jerjes‐Sánchez, et al.
Published: (2024-04-01)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
by: M. A. Manukyan, et al.
Published: (2021-11-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension
by: Bingbing Ye, et al.
Published: (2022-07-01)

Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials
by: Catherine M. Avitabile, et al.
Published: (2024-01-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023-07-01)

Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
by: Markku Pentikäinen, et al.
Published: (2025-01-01)

COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals
by: E. A. Rezukhina, et al.
Published: (2021-11-01)

Case Series Evaluating the Relationship of SGLT2 Inhibition to Pulmonary Artery Pressure and Non-Invasive Cardiopulmonary Parameters in HFpEF/HFmrEF Patients—A Pilot Study
by: Ester Judith Herrmann, et al.
Published: (2025-01-01)

Flow Cytometric Determination of Circulating Progenitor Cells in Patients With Pulmonary Arterial Hypertension: A Systematic Review
by: Kimia Heydari, et al.
Published: (2025-01-01)

Usefulness of pulmonary artery diameter in diagnosing pulmonary hypertension in patients admitted to tuberculosis intensive care unit
by: Armin Nowroozpoor, et al.
Published: (2016-01-01)

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland
by: Markku Pentikäinen, et al.
Published: (2024-12-01)

Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team
by: Valentin Coirier, et al.
Published: (2021-09-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)

Recent trends in pulmonary arterial hypertension
by: Rajagopalan Natarajan
Published: (2011-01-01)

Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
by: Alban Todesco, et al.
Published: (2024-07-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
by: Eglė Palevičiūtė, et al.
Published: (2023-04-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024-09-01)

Rehabilitation in patients with pulmonary arterial hypertension
by: Stephan Keusch, et al.
Published: (2017-07-01)

Mortality from pulmonary hypertension in Europe 2001-2019
by: Adam Hartley, et al.
Published: (2024-08-01)

Epidemiological and clinical characteristics of pulmonary arterial hypertension in Indian patients: A hospital-based observational study
by: Mithilesh Kulkarni, et al.
Published: (2023-01-01)

Cardiovascular magnetic resonance in pulmonary hypertension
by: Bradlow William M, et al.
Published: (2012-01-01)

2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary
by: Jae-Hyeong Park, et al.
Published: (2022-01-01)

Pulmonary arterial hypertension: diagnosis and treatment
by: Marcin Sadowski, et al.
Published: (2013-10-01)

New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01)

Short‐Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4‐Dimensional–Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension
by: Michal Schäfer, et al.
Published: (2021-04-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Pulmonary arterial banding in mice may be a suitable model for studies on ventricular mechanics in pediatric pulmonary arterial hypertension
by: Melanie J. Dufva, et al.
Published: (2021-06-01)

Evaluation of radiographic pulmonary artery diameter and echocardiographic pulmonary artery pressure in COPD patients in South-West Nigeria
by: Zuliat A. Awoyemi, et al.
Published: (2025-07-01)

Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes
by: Abdulrahman Abouzaid, et al.
Published: (2024-09-01)

Pulmonary arterial hypertension in the elderly: Clinical perspectives
by: Nicholas Rothbard, et al.
Published: (2020-05-01)